PROTOPAM CHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Protopam Chloride patents expire, and what generic alternatives are available?
Protopam Chloride is a drug marketed by Baxter Hlthcare Corp and Wyeth Ayerst and is included in two NDAs.
The generic ingredient in PROTOPAM CHLORIDE is pralidoxime chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralidoxime chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROTOPAM CHLORIDE?
- What are the global sales for PROTOPAM CHLORIDE?
- What is Average Wholesale Price for PROTOPAM CHLORIDE?
Summary for PROTOPAM CHLORIDE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Patent Applications: | 504 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for PROTOPAM CHLORIDE |
| What excipients (inactive ingredients) are in PROTOPAM CHLORIDE? | PROTOPAM CHLORIDE excipients list |
| DailyMed Link: | PROTOPAM CHLORIDE at DailyMed |
Pharmacology for PROTOPAM CHLORIDE
| Drug Class | Cholinesterase Reactivator |
| Mechanism of Action | Cholinesterase Reactivators |
US Patents and Regulatory Information for PROTOPAM CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | PROTOPAM CHLORIDE | pralidoxime chloride | INJECTABLE;INJECTION | 014134-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | PROTOPAM CHLORIDE | pralidoxime chloride | TABLET;ORAL | 014122-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
